✦ LIBER ✦

A phase I study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support in the treatment of advanced non-small cell lung cancer

✍ Scribed by K. Mori; T. Hirose; S. Machida; K. Yokoyama; K. Tominaga

Book ID: 117665397
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 275 KB
Volume: 33
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(97)89030-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of irinotecan and infus

A phase II study of irinotecan and infusional cisplatin with recombinant human granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer

✍ Kiyoshi Mori; Suguru Machida; Takeshi Yoshida; Munehide Yoshida; Yasuliko Kano; 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 68 KB

A phase I study of irinotecan and infusi

A phase I study of irinotecan and infusional cisplatin for advanced non-small-cell lung cancer

✍ K. Mori; Tsukasa Ohnishi; Kohki Yokoyama; Keigo Tominaga 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 128 KB

Phase I trial of irinotecan and amrubici

Phase I trial of irinotecan and amrubicin with granulocyte colony-stimulating factor support in extensive-stage small-cell lung cancer

✍ Asakuma, Maiko; Yamamoto, Michiko; Wada, Mayuko; Ryuge, Shinichiro; Katono, Ken; 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 196 KB

Phase II study of cisplatin as a 5-day c

Phase II study of cisplatin as a 5-day continuous infusion with vindesine plus recombinant human granulocyte-colony-stimulating factor in the treatment of advanced non-small-cell lung cancer

✍ Yoshikuni Saito; Kiyoshi Mori; Keigo Tominaga; Kouhei Yokoi; Naoto Miyazawa 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 500 KB

A phase I clinical and pharmacologic stu

A phase I clinical and pharmacologic study of a carboplatin and irinotecan regimen combined with recombinant human granulocyte-colony stimulating factor in the treatment of patients with advanced nonsmall cell lung carcinoma

✍ Hiroaki Okamoto; Akira Nagatomo; Hideo Kunitoh; Hiroshi Kunikane; Koshiro Watana 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

BACKGROUND. This Phase I study was designed to determine the toxicity and efficacy of a carboplatin and irinotecan (CPT-11) regimen with recombinant human granulocyte colony-stimulating factor (rhG-CSF) support for patients with advanced nonsmall cell lung carcinoma. ## METHODS. Treatment consist

Phase I–II study of irinotecan (CPT-11)

Phase I–II study of irinotecan (CPT-11) plus nedaplatin (254-S) with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer

✍ Tsuda, H; Hashiguchi, Y; Nishimura, S; Miyama, M; Nakata, S; Kawamura, N; Negoro 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 101 KB